It is suggested that the reduction in nitric oxide availability resulting from insulin resistance may trigger systemic inflammation, leading to the release of pro‐inflammatory mediators,24 and an increase in reactive oxygen species production, potentially caused by impaired mitochondrial function and viability resulting from an influx of fatty acids to compensate for a deficit in insulin.25 This evidence concerns the gene INS and Insulin resistance.